Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Collegium Pharmaceutical, Inc. (COLL) had Return on Tangible Equity of -8.39% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$631.45M
Net Income	$69.19M
Cost of Goods Sold	$254.10M
Gross Profit	$377.34M
Operating Expenses	$461.55M
Operating Income	$169.90M
Non-Operating Income/Expense	$-71.33M
Pre-Tax Income	$98.57M
Normalized Pre-Tax Income	$98.57M
Income after Taxes	$69.19M
Income from Continuous Operations	$69.19M
Consolidated Net Income/Loss	$69.19M
Normalized Income after Taxes	$69.19M
EBIT	$169.90M
EBITDA	$337.03M
Weighted-Average Shares Outstanding (Basic)	32.27M
Weighted-Average Shares Outstanding (Diluted)	40.42M
Earnings per Share (EPS) (Basic)	$2.14
Earnings per Share (EPS) (Diluted)	$1.86
Balance Sheet Financials
Current Assets	$482.26M
Property, Plant, and Equipment	$14.33M
Long-Term Assets	$1.18B
Total Assets	$1.66B
Current Liabilities	$509.51M
Long-Term Debt	$787.90M
Long-Term Liabilities	$925.24M
Total Liabilities	$1.43B
Common Equity	$228.84M
Tangible Shareholders Equity	$-824.89M
Shareholders Equity	$228.84M
Common Shares Outstanding	31.44M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$204.98M
Cash Flow from Investing Activities	$-287.76M
Cash Flow from Financial Activities	$-60.60M
Beginning Cash	$239.99M
End Cash	$96.61M
Increase/Decrease in Cash	$-143.38M
Stock-Based Compensation	$32.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.77
Debt to Equity Ratio	3.73
Gross Margin	59.76%
Operating Margin	26.91%
EBIT Margin	26.91%
EBITDA Margin	53.37%
Pre-Tax Profit Margin	15.61%
Profit Margin	10.96%
Free Cash Flow	$203.33M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.38
Inventory Turnover	7.15
Receiveable Turnover	2.76
Days Sales in Receivables	132.10
Return on Equity	30.23%
Return on Tangible Equity	-8.39%
Return on Assets	4.16%
Return on Investments	6.80%
Book Value Per Share	$7.28
Free Cash Flow per Share	$5.03
Operating Cash Flow per Share	$5.07

Data from Zacks Investment Research, Inc.